Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Pexacerfont

Generic Name: Pexacerfont

Drug Type: Small Molecule

Chemical Formula: C_₁₈H_₂₄N_₆O

CAS Number: 459856-18-9

Unique Ingredient Identifier: LF1VBG4ZUK

Overview

Pexacerfont has been investigated for the treatment of Alcoholism, Anxiety Disorder, Alcohol Dependence, and Alcohol-Related Disorders.

Background

Pexacerfont has been investigated for the treatment of Alcoholism, Anxiety Disorder, Alcohol Dependence, and Alcohol-Related Disorders.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Pexacerfont for Stress-induced Food Craving

Early Phase 1

Terminated

Posted: 2012/08/03

Sponsor:National Institute o...

ID:NCT01656577

Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^

Phase 2

Completed

Posted: 2010/10/25

Sponsor:

National Institute o...

ID:NCT01227980

Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder

Phase 2

Completed

Posted: 2007/06/01

Sponsor:Bristol-Myers Squibb

ID:NCT00481325

A Study of BMS-562086 in Patients With Irritable Bowel Syndrome

Phase 2

Completed

Posted: 2006/11/14

Sponsor:Bristol-Myers Squibb

ID:NCT00399438

Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder

Phase 1

Completed

Posted: 2005/08/26

Sponsor:Bristol-Myers Squibb

ID:NCT00135421

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy